We identified two clusters of PBMC kinomic profile at D0 among NSCLC patients, which differed from healthy volunteers’ profiles, and demonstrated that nivolumab therapy induces substantial changes in STK activities, particularly in those involved in phosphoinositide 3-kinase (PI3K/Akt) pathway. Here, AKT1 is linked to non-small cell lung carcinoma.